title: Elevated plasma TGF-beta1 in renal diseases: cause or consequence?
abstract: We previously reported elevated levels of TGF-beta1 in patients with renal carcinoma. Certain aspects led us to ask whether they might be caused by chronic damage to the kidney(s). Here we report on an extended set of patients with various renal diseases, lung cancer, humoral immunodeficiency and controls. For latent TGF-beta1 in plasma, we find that the control, immunodeficiency, lung cancer and kidney transplant groups do not differ significantly (means, 7.0-8.8 ng/ml). Also, acute short-term renal stress (extracorporal lithotrypsy) does not lead to an increase of TGF-beta1. However, the pyelonephritis patients present with levels of 19.0 ng/ml, chronic extracorporal dialysis patients with 15.5 ng/ml, and renal cell carcinoma patients with 22.8 ng/ml. For active TGF-beta1 these findings are exactly recovered. For serum levels, only the renal carcinoma group presents with significantly elevated levels of TGF-beta1. Kidney transplantation seems to normalize TGF-beta1 levels, while in the kidney cancer patients surgery has an effect only in part of the group. We conclude that elevated plasma TGF-beta1 levels are common in at least two chronic renal disease conditions, and that it normalizes with restoration of renal function. It is tempting to speculate that chronic elevation of TGF-beta1 in these patients may be critically involved in these conditions predisposing to renal cancer.
authors.affiliation: Institute of Clinical Immunology, Friedrich-Schiller-University, Jena, Germany. iuj@RZ.Uni-Jena.De
authors.forename: U
authors.initials: U
authors.lastname: Junker
authors.forename: C C
authors.initials: CC
authors.lastname: Haufe
authors.forename: K
authors.initials: K
authors.lastname: Nuske
authors.forename: K
authors.initials: K
authors.lastname: Rebstock
authors.forename: T
authors.initials: T
authors.lastname: Steiner
authors.forename: H
authors.initials: H
authors.lastname: Wunderlich
authors.forename: K
authors.initials: K
authors.lastname: Junker
authors.forename: D
authors.initials: D
authors.lastname: Reinhold
mesh_terms: D002292:Carcinoma, Renal Cell / Q000097:blood / Q000276:immunology; D017074:Common Variable Immunodeficiency / Q000097:blood / Q000276:immunology; D006801:Humans; D007674:Kidney Diseases / Q000097:blood*; D007676:Kidney Failure, Chronic / Q000097:blood / Q000276:immunology; D007680:Kidney Neoplasms / Q000097:blood / Q000276:immunology; D016030:Kidney Transplantation / Q000276:immunology; D008096:Lithotripsy; D008175:Lung Neoplasms / Q000097:blood / Q000276:immunology; D011704:Pyelonephritis / Q000097:blood / Q000276:immunology; D016212:Transforming Growth Factor beta / Q000097:blood*
chemical_list: D016212:Transforming Growth Factor beta